{
    "name": "Apert Syndrome",
    "slug": "apert-syndrome",
    "aliases": [
        "Acrocephalosyndactyly Type I",
        "ACS1"
    ],
    "description": "Apert syndrome is a rare genetic disorder characterized by craniosynostosis (premature fusion of certain skull bones) and syndactyly (fusion) of the fingers and toes. The severity of these features can vary among affected individuals. Other common features include midface hypoplasia, which can lead to breathing and feeding difficulties, as well as dental abnormalities and intellectual disability in some cases.",
    "category": "GENETIC",
    "icdCode": "Q87.0",
    "orphaCode": "85",
    "omimCode": "101200",
    "prevalence": "1 in 65,000 to 1 in 88,000 live births",
    "estimatedCases": 5000,
    "ageOfOnset": "Congenital (at birth)",
    "inheritance": "SPORADIC (mostly new mutations), AUTOSOMAL_DOMINANT (rarely inherited)",
    "symptoms": [
        "Craniosynostosis (premature fusion of skull bones)",
        "Syndactyly (fusion of fingers and toes)",
        "Midface hypoplasia (underdevelopment of the midface)",
        "Dental abnormalities (e.g., crowded teeth, open bite)",
        "Hydrocephalus (accumulation of fluid in the brain)",
        "Intellectual disability (variable)",
        "Choanal stenosis or atresia (narrowing or blockage of nasal passages)",
        "Hearing loss",
        "Acne"
    ],
    "affectedSystems": [
        "Skeletal System",
        "Craniofacial Structures",
        "Integumentary System",
        "Respiratory System",
        "Neurological System"
    ],
    "prognosis": "Variable, depending on the severity of symptoms and the success of surgical interventions. Early intervention and comprehensive management can improve the quality of life.",
    "lifeExpectancy": "Near normal with appropriate medical management, but complications can reduce lifespan.",
    "diagnosticMethods": [
        "Clinical examination",
        "Radiographic imaging (X-rays, CT scans)",
        "Genetic testing (FGFR2 gene sequencing)"
    ],
    "treatmentOptions": [
        {
            "name": "Cranial Vault Remodeling",
            "type": "SURGERY",
            "effectiveness": "HIGHLY_EFFECTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Midface Advancement",
            "type": "SURGERY",
            "effectiveness": "MODERATELY_EFFECTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Syndactyly Release",
            "type": "SURGERY",
            "effectiveness": "HIGHLY_EFFECTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Tracheostomy",
            "type": "SURGERY",
            "effectiveness": "SUPPORTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Ventricular Shunt Placement",
            "type": "SURGERY",
            "effectiveness": "HIGHLY_EFFECTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Speech Therapy",
            "type": "THERAPY",
            "effectiveness": "SUPPORTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Occupational Therapy",
            "type": "THERAPY",
            "effectiveness": "SUPPORTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Special Education",
            "type": "SUPPORTIVE",
            "effectiveness": "SUPPORTIVE",
            "fdaApproved": null,
            "approvalYear": null
        },
        {
            "name": "Antibiotics",
            "type": "MEDICATION",
            "effectiveness": "SUPPORTIVE",
            "fdaApproved": true,
            "approvalYear": null
        }
    ],
    "researchStatus": "ACTIVE_TRIALS",
    "clinicalTrialsCount": 15,
    "keyResearchCenters": [
        "Seattle Children's Hospital",
        "Johns Hopkins Children's Center",
        "Children's Hospital of Philadelphia",
        "Stanford Children's Health"
    ],
    "patientOrganizations": [
        {
            "name": "AboutFace",
            "url": "https://www.aboutface.ca/",
            "country": "Canada"
        },
        {
            "name": "FACES: The National Craniofacial Association",
            "url": "https://faces-cranio.org/",
            "country": "USA"
        }
    ],
    "relatedConditions": [
        "Pfeiffer Syndrome",
        "Crouzon Syndrome",
        "Saethre-Chotzen Syndrome"
    ],
    "specialistTypes": [
        "Clinical Geneticist",
        "Craniofacial Surgeon",
        "Plastic Surgeon",
        "Neurosurgeon",
        "Ophthalmologist",
        "ENT Specialist",
        "Developmental Pediatrician"
    ],
    "eli5Summary": "Apert syndrome is when a baby's skull bones fuse too early, and their fingers and toes are often fused together. Doctors can do surgery to help fix these problems so the child can grow and develop better.",
    "clinicalSummary": "Apert syndrome (ACS1) is a rare autosomal dominant genetic disorder characterized by craniosynostosis, midface hypoplasia, and syndactyly of the hands and feet. The underlying pathology involves mutations in the FGFR2 gene, leading to constitutive activation of the fibroblast growth factor receptor signaling pathway, resulting in premature osteoblast differentiation and fusion of cranial sutures. Clinical manifestations include a turribrachycephalic skull shape, shallow orbits, proptosis, choanal stenosis, and variable degrees of intellectual disability. Diagnosis is typically made clinically and confirmed by genetic testing. Management involves a multidisciplinary approach, including staged surgical procedures to address craniosynostosis, midface hypoplasia, and syndactyly. Long-term follow-up is essential to monitor for complications such as increased intracranial pressure, hydrocephalus, and airway obstruction.",
    "historicalBackground": "Apert syndrome was first described in detail by French physician Eug√®ne Apert in 1906. He characterized the condition based on the distinct combination of craniosynostosis and syndactyly observed in affected individuals.",
    "recentBreakthroughs": [
        {
            "year": 2022,
            "title": "3D Printing for Surgical Planning in Apert Syndrome",
            "description": "3D printing technology is increasingly used for pre-surgical planning in complex craniofacial reconstructions for Apert syndrome patients, improving surgical precision and outcomes.",
            "sourceUrl": null
        },
        {
            "year": 2023,
            "title": "Longitudinal Study on Cognitive Development in Apert Syndrome",
            "description": "A longitudinal study is underway to better understand the cognitive development trajectories of individuals with Apert syndrome, aiming to identify early intervention strategies to optimize neurodevelopmental outcomes.",
            "sourceUrl": null
        }
    ],
    "heroImage": null,
    "diagrams": [],
    "lastUpdated": "2024-12-01",
    "reviewedBy": "MDRPedia Medical Team",
    "sources": [
        {
            "name": "National Organization for Rare Disorders (NORD)",
            "url": "https://rarediseases.org/"
        },
        {
            "name": "MedlinePlus",
            "url": "https://medlineplus.gov/"
        },
        {
            "name": "Orphanet",
            "url": "https://www.orpha.net/"
        }
    ]
}